March 14, 2022
Nordic Nanovector ASA – Final results of the subsequent offering
Media
March 10, 2022
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
March 10, 2022
Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events
March 10, 2022
Xeris Announces $150M Senior Secured Term Loan Facility With Hayfin Capital
March 10, 2022
Digital mental health company HelloBetter raises Series A extension led by MassMutual Ventures
March 09, 2022
Vicore strengthens rare lung disease pipeline with PAH indication
March 09, 2022
Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting
March 09, 2022
Targovax ASA: Poster presentation at the AACR Annual Meeting
March 07, 2022
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
March 04, 2022
Xeris Biopharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
